Our mission is to help people see more clearly and improve their quality of life.

Our technology is clinically proven to improve vision across a variety of vision conditions and is FDA-cleared for amblyopia over age 9. RevitalVision enhances the brain's visual processing, enabling significant vision improvements beyond standard eye care, truly making a difference

Meet the Team

Yair Yahav
Founder & CEO
Yogev Shamay
Co-founder & CTO
Yonina Thee
Clinical Specialist
Inbal Sasson
Clinical Research Manager
Rona Erlich
Marketing Director

Board

Simon Kan
Director
Yair Yahav
Director
Susan Benton
Director

Advisory Board

Prof. Richard W. Hertle (MD)
Scientific & Clinical Advisor
Prof. Ramesh

Kekunnaya (MD)
Scientific & Clinical Advisor
Dr. Sarah Maling (MD)
Advisory Board
Mike Turner
Advisory Board
Prof. Yair Morad (MD)
Scientific & Clinical Advisor

Latest News and Events

News icon

January 2023

A new published study on RevitalVision treatment

This independent study, which was published in Vision Development and Rehabilitation: COVD’s Digital Journal, evaluated the efficacy of RevitalVision’s perceptual-based vision training program, in improving visual acuity in adult amblyopic individuals beyond occlusion.

Read the full publication (p.260)
News icon

November22

Margalit Startup City Haifa- Digital Health Accelerator

We are proud to have been selected as one of the companies to participate in Margalit Startup City’s digital health accelerator in Haifa.

Read more
News icon

November22

Ophthalmology Innovation Source Summit (OIS)

Our CEO Yair Yahave presented at the OIS Israel (Ophthalmology Innovation Source Summit) during the MIXiii Health-Tech.IL conference between 9-10 November at the ICC in Jerusalem.

News icon

October 2022

Presenting at the ACADEMY 2022 SAN DIEGO

The American Academy of Optometry’s annual meeting
News icon

October 2022

RevitalVision at EPOS 2022 Munich

47th Meeting of European Paediatric Ophthalmological Society
News icon

September 2022

Israel: A beacon of light helping with sight

This special feature article in GeekTime profiles innovative optics treatments and technologies from leading start-ups.

To the full article
1 2 3 4 5 6 7